Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Price
Target price
€337.65

€337.65

-1.020%
-3.5
-1.020%
€476.01
 
22.08.25 / Tradegate WKN: 882807 / Symbol: VRTX / Name: Vertex / Stock / Biotechnology & Medical Research / Large Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.

sharewise BeanCounterBot

The analysis provided is generated by an artificial intelligence system and is provided for informational purposes only. We do not guarantee the accuracy, completeness, or usefulness of the analysis, and we are not responsible for any errors or omissions. Use of the analysis is at your own risk.
The full analysis of the stock Vertex Pharmaceuticals Inc. is only available for our menbers.
Not a member yet? Sign up for free!

Financial data and news for Vertex

sharewise wants to provide you with the best news and tools for Vertex, so we directly link to the best financial data sources.

News

Best Biotech Stocks to Buy in 2025
Best Biotech Stocks to Buy in 2025

The bear market induced by the Federal Reserve’s monetary tightening officially ended in 2023, but it seems no one remembered to tell the biotech sector.

Biotech stocks lagged the broader market

Vertex Stock: Executives Sell Shares Amid Strong Performance
Vertex Stock: Executives Sell Shares Amid Strong Performance

Vertex Pharmaceuticals Inc. has seen significant insider selling activity recently, with top executives divesting substantial shareholdings while the company's stock enjoys impressive performance

What's Wrong With Vertex Pharmaceuticals Stock?: https://g.foolcdn.com/editorial/images/829633/a-group-of-scientists-looking-at-a-report.jpg
What's Wrong With Vertex Pharmaceuticals Stock?

Vertex Pharmaceuticals (NASDAQ: VRTX) has been a top pharma stock in recent years. It has been generating strong revenue growth while also building out its portfolio of drugs, expanding its growth

Here's How This Forgotten Healthcare Stock Could Generate Life-Changing Returns: https://g.foolcdn.com/editorial/images/824353/scientist-altering-dna-genome-project.jpg
Here's How This Forgotten Healthcare Stock Could Generate Life-Changing Returns

Over the past few years, the market hasn't been kind to somewhat speculative, unprofitable stocks. CRISPR Therapeutics (NASDAQ: CRSP), a mid-cap biotech, fits that description. The company's shares

Is This Beaten-Down Stock a Buy on the Dip?: https://g.foolcdn.com/editorial/images/828966/physician-giving-medicine-to-elderly-patient.jpg
Is This Beaten-Down Stock a Buy on the Dip?

Even well-established drugmakers can lose significant market value overnight following a setback. That's what recently happened to Vertex Pharmaceuticals (NASDAQ: VRTX). The company's shares fell by

7 Reasons Why Vertex Pharmaceuticals Is a No-Brainer Stock to Buy on the Dip: https://g.foolcdn.com/editorial/images/828065/scientist-in-lab-young-african-american-female.jpg
7 Reasons Why Vertex Pharmaceuticals Is a No-Brainer Stock to Buy on the Dip

Vertex Pharmaceuticals (NASDAQ: VRTX) reported its second-quarter results after the market closed on Monday. Its shares plunged more than 17% in early trading on Tuesday.

Were Vertex's Q2 results

Up 50% in 3 Months, Is This Stock Still a Buy?: https://g.foolcdn.com/editorial/images/827432/scientist-altering-dna-genome-project.jpg
Up 50% in 3 Months, Is This Stock Still a Buy?

Is this finally the year CRISPR Therapeutics (NASDAQ: CRSP) bounces back? The biotech has lagged the market in recent years, but shares are up 50% over the past three months and have climbed 42%

The 3 Things That Matter for Vertex Pharmaceuticals Now: https://g.foolcdn.com/editorial/images/825400/pharmacist-talking-to-patient.jpg
The 3 Things That Matter for Vertex Pharmaceuticals Now

Vertex Pharmaceuticals (NASDAQ: VRTX) has been a terrific stock to own over the past decade. The stock has outperformed the market over this period, thanks to consistent financial results and

The Best Stocks to Invest $1,000 in Right Now: https://g.foolcdn.com/editorial/images/824452/person-smiling-and-looking-at-laptop.jpg
The Best Stocks to Invest $1,000 in Right Now

What if you only had $1,000 to invest in stocks and had to put the money to work today? Which stocks would you buy? That's admittedly not an easy question to answer. I can think of lots of stocks

3 Growth Stocks You Can Buy Right Now Without Any Hesitation: https://g.foolcdn.com/editorial/images/821591/woman-smiling-laptop.jpg
3 Growth Stocks You Can Buy Right Now Without Any Hesitation

You're unlikely to have a warm-and-fuzzy feeling after buying some stocks. Instead, some stocks can keep you awake at night because of their high volatility and risk. The good news, though, is that

3 Reasons to Buy Vertex Pharmaceuticals Stock Like There's No Tomorrow: https://g.foolcdn.com/editorial/images/819629/gettyimages-1129386267.jpg
3 Reasons to Buy Vertex Pharmaceuticals Stock Like There's No Tomorrow

The three major indexes slid in March and April as investors worried about the impact of President Donald Trump's import tariffs on the economy -- but in recent weeks, optimism about lower, more

Prediction: This Beaten-Down Stock Could Double in The Next 5 Years
Prediction: This Beaten-Down Stock Could Double in The Next 5 Years

Despite making significant clinical progress, CRISPR Therapeutics (NASDAQ: CRSP) has been struggling financially in the past three years. The company's shares are down by 24% over this period, while

This Stock Just Dropped by 12% in 1 Day. History Says This Will Happen Next
This Stock Just Dropped by 12% in 1 Day. History Says This Will Happen Next

Vertex Pharmaceuticals (NASDAQ: VRTX), a leading drugmaker, is performing exceedingly well for the year -- or at least it was, until it released its first-quarter update. The results were not to the

Why Vertex Pharmaceuticals Stock Is a Screaming Buy on the Dip
Why Vertex Pharmaceuticals Stock Is a Screaming Buy on the Dip

Vertex Pharmaceuticals' (NASDAQ: VRTX) remarkable momentum came to a screeching halt this week. The big biotech stock had been up well over 20% year to date. However, Vertex's shares plunged after

Why Vertex Pharmaceuticals Stock Is Sinking Today
Why Vertex Pharmaceuticals Stock Is Sinking Today

Shares of Vertex Pharmaceuticals (NASDAQ: VRTX) were sinking 11.9% as of 10:18 a.m. ET on Tuesday. The sharp decline came after the company announced its 2025 first-quarter results on Monday

Rising Costs Weigh on Vertex Q1 Earnings
Rising Costs Weigh on Vertex Q1 Earnings

Here's our initial take on Vertex Pharmaceuticals' (NASDAQ: VRTX) first-quarter financial report.

Vertex's first-quarter financial results didn't keep up with what investors have gotten used to

3 No-Brainer Stocks to Buy in May
3 No-Brainer Stocks to Buy in May

Any time is a great time to buy stocks -- if you pick the right stocks. That's true even in May, a month where some investors have traditionally opted to take a break from the stock market for the

Why Vertex Pharmaceuticals Was Such a Healthy Stock on Tuesday
Why Vertex Pharmaceuticals Was Such a Healthy Stock on Tuesday

Vertex Pharmaceuticals (NASDAQ: VRTX) had a fine Tuesday on the stock exchange. The biotech's shares closed the day nearly 3% higher in price, on the back of two positive mentions by analysts

Don't Try to Time the Market: These 2 Stocks Are Buys Regardless of What Happens Next
Don't Try to Time the Market: These 2 Stocks Are Buys Regardless of What Happens Next

Equity markets have been seesawing for the past two weeks. Stocks fell hard after President Donald Trump announced his tariff plans, then bounced back big once he said he would pause expanded

Could CRISPR Therapeutics Become the Next Vertex Pharmaceuticals?
Could CRISPR Therapeutics Become the Next Vertex Pharmaceuticals?

Vertex Pharmaceuticals (NASDAQ: VRTX) is a great example of biotech success. The company has built a cystic fibrosis (CF) empire, bringing in billions of dollars in revenue annually, and now is even

Is Vertex Pharmaceuticals Stock a Buy?
Is Vertex Pharmaceuticals Stock a Buy?

Investors seeking relief from the stock market turbulence at the start of 2025 should take a close look at Vertex Pharmaceuticals (NASDAQ: VRTX). Compared to the S&P 500 index, which is down about

2 Stocks to Buy if You're Worried About a Recession
2 Stocks to Buy if You're Worried About a Recession

Is a recession coming? Our economic outlook seems increasingly gloomy due to President Trump's trade policies. Though things might not go that far, it's still worth planning ahead.

If a recession

3 Unstoppable Stocks You Can Buy Now Without Any Hesitation
3 Unstoppable Stocks You Can Buy Now Without Any Hesitation

Are you reluctant to invest in stocks right now? That's understandable. Fear, uncertainty, and doubt have become the norm in early 2025 with rising stock market volatility.

However, three Fool.com

Where Will Vertex Pharmaceuticals Be in 10 Years?
Where Will Vertex Pharmaceuticals Be in 10 Years?

The past decade has been a game-changing one for Vertex Pharmaceuticals (NASDAQ: VRTX). The biotech won approval for its first cystic fibrosis (CF) drug -- Kalydeco -- back in 2012 and has since

If I Could Buy Only 1 Growth Stock, This Would Be It
If I Could Buy Only 1 Growth Stock, This Would Be It

There are hundreds of publicly traded companies on various equity markets worldwide. Investors choose to put their hard-earned money into specific companies based on their preferences, risk